Now showing items 51-60 of 197
Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study
(John Wiley & Sons, Inc., 2020-07)
In the US, mortality in sickle cell disease (SCD) increases after age 18- 20- years. Biomarkers of mortality risk can identify patients who need intensive follow- up and early or novel interventions. We prospectively ...
A Sardinian founder mutation in glycoprotein Ib platelet subunit beta (GP1BB) that impacts thrombocytopenia
(Wiley Periodicals, Inc., 2020-12)
High‐level induction of fetal haemoglobin by pomalidomide in β‐thalassaemia/HbE erythroid progenitor cells
(Wiley Periodicals, Inc., 2020-06)
Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B‐cell lymphoma
(John Wiley & Sons, Inc., 2020-01)
This phase 1b/2, multicenter, open‐label study evaluated ibrutinib plus durvalumab in relapsed/refractory follicular lymphoma (FL) or diffuse large B‐cell lymphoma (DLBCL). Patients were treated with once‐daily ibrutinib ...
Norepinephrine may be an underlying factor in chemobrain
(John Wiley & Sons, Inc., 2021-06-15)
Trends and racial disparities in aggressive end‐of‐life care for a national sample of women with ovarian cancer
(The National Academies PressWiley Periodicals, Inc., 2021-07-01)
Vaccination against COVID- 19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders
(BioNTechWiley Periodicals, Inc., 2021-07)
Breast cancer patients’ insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG‐ACRIN TAILORx trial
(American Cancer SocietyWiley Periodicals, Inc., 2021-07-15)
Diagnostic mesothelioma biomarkers in effusion cytology
(Wiley Periodicals, Inc., 2021-07)
Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre’s readiness in United States and EU
(Wiley Periodicals, Inc., 2021-07)